Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rahemtulla

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1990
Expression of a T cell receptor gamma-chain (V gamma 1.1J gamma 4C gamma 4) transgene in mice influences T cell receptor ontogeny and thymic architecture during developmentD A Ferrick, A Chan, A Rahemtulla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodiesA A Epenetos, A J Munro, S Stewart, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulationS M Ensminger, B M Spriewald, H V Sorensen, et al.
Nature|September 12, 1991
Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4A Rahemtulla, W P Fung-Leung, M W Schilham, et al.
Bone Marrow Transplantation|February 28, 2006
Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patientsD O'Shea, C Giles, E Terpos, et al.
Leukemia|February 11, 2005
Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapseD Marin, J Kaeda, R Szydlo, et al.
Leukemia|March 16, 2007
Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacyM P Simula, S Marktel, C Fozza, et al.
British Journal of Haematology|February 3, 2005
Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning--evidence for a superior outcome using melphalan combined with total body irradiationH M Hunter, K Peggs, R Powles, et al.
Bone Marrow Transplantation|June 27, 2017
Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservationJ Pavlů, H W Auner, R M Szydlo, et al.
Bone Marrow Transplantation|November 23, 2006
LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centreJ B Perz, C Giles, R Szydlo, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1990
Expression of a T cell receptor gamma-chain (V gamma 1.1J gamma 4C gamma 4) transgene in mice influences T cell receptor ontogeny and thymic architecture during developmentD A Ferrick, A Chan, A Rahemtulla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodiesA A Epenetos, A J Munro, S Stewart, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulationS M Ensminger, B M Spriewald, H V Sorensen, et al.
Nature|September 12, 1991
Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4A Rahemtulla, W P Fung-Leung, M W Schilham, et al.
Bone Marrow Transplantation|February 28, 2006
Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patientsD O'Shea, C Giles, E Terpos, et al.
Leukemia|February 11, 2005
Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapseD Marin, J Kaeda, R Szydlo, et al.
Leukemia|March 16, 2007
Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacyM P Simula, S Marktel, C Fozza, et al.
British Journal of Haematology|February 3, 2005
Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning--evidence for a superior outcome using melphalan combined with total body irradiationH M Hunter, K Peggs, R Powles, et al.
Bone Marrow Transplantation|June 27, 2017
Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservationJ Pavlů, H W Auner, R M Szydlo, et al.
Bone Marrow Transplantation|November 23, 2006
LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centreJ B Perz, C Giles, R Szydlo, et al.
Pageof 7